Concourse Financial Group Securities’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-200
| Closed | -$69.6K | – | 8429 |
|
|
2024
Q4 | $69.6K | Buy |
200
+1
| +0.5% | +$348 | ﹤0.01% | 1067 |
|
|
2024
Q3 | $59.7K | Sell |
199
-51
| -20% | -$15.3K | ﹤0.01% | 1118 |
|
|
2024
Q2 | $82.3K | Buy |
250
+6
| +2% | +$1.98K | 0.01% | 990 |
|
|
2024
Q1 | $96.6K | Buy |
244
+4
| +2% | +$1.58K | 0.01% | 925 |
|
|
2023
Q4 | $84.5K | Buy |
240
+8
| +3% | +$2.82K | 0.01% | 947 |
|
|
2023
Q3 | $87K | Sell |
232
-46
| -17% | -$17.3K | 0.01% | 899 |
|
|
2023
Q2 | $106K | Buy |
278
+14
| +5% | +$5.36K | 0.01% | 859 |
|
|
2023
Q1 | $91.5K | Sell |
264
-32
| -11% | -$11.1K | 0.01% | 893 |
|
|
2022
Q4 | $69.7K | Sell |
296
-2,264
| -88% | -$533K | 0.01% | 948 |
|
|
2022
Q3 | $630K | Sell |
2,560
-150
| -6% | -$36.9K | 0.06% | 307 |
|
|
2022
Q2 | $819K | Sell |
2,710
-902
| -25% | -$273K | 0.07% | 285 |
|
|
2022
Q1 | $1.48M | Sell |
3,612
-207
| -5% | -$85K | 0.11% | 185 |
|
|
2021
Q4 | $1.79M | Buy |
3,819
+89
| +2% | +$41.7K | 0.1% | 196 |
|
|
2021
Q3 | $1.58M | Sell |
3,730
-826
| -18% | -$351K | 0.1% | 209 |
|
|
2021
Q2 | $1.64M | Buy |
4,556
+412
| +10% | +$148K | 0.1% | 190 |
|
|
2021
Q1 | $1.17M | Buy |
4,144
+78
| +2% | +$22K | 0.08% | 222 |
|
|
2020
Q4 | $1.15M | Buy |
4,066
+185
| +5% | +$52.4K | 0.09% | 204 |
|
|
2020
Q3 | $1.07M | Sell |
3,881
-421
| -10% | -$116K | 0.09% | 183 |
|
|
2020
Q2 | $977K | Buy |
4,302
+425
| +11% | +$96.5K | 0.09% | 167 |
|
|
2020
Q1 | $590K | Buy |
3,877
+825
| +27% | +$126K | 0.07% | 224 |
|
|
2019
Q4 | $459K | Buy |
3,052
+1,912
| +168% | +$288K | 0.05% | 311 |
|
|
2019
Q3 | $162K | Buy |
1,140
+884
| +345% | +$126K | 0.04% | 333 |
|
|
2019
Q2 | $32K | Buy |
256
+21
| +9% | +$2.63K | ﹤0.01% | 1041 |
|
|
2019
Q1 | $25K | Buy |
235
+69
| +42% | +$7.34K | ﹤0.01% | 1182 |
|
|
2018
Q4 | $16K | Sell |
166
-16
| -9% | -$1.54K | ﹤0.01% | 1260 |
|
|
2018
Q3 | $22K | Buy |
+182
| New | +$22K | 0.01% | 830 |
|